Ani Pharmaceuticals (ANIP) Other Gross PP&E Adjustments: 2011-2025
Historic Other Gross PP&E Adjustments for Ani Pharmaceuticals (ANIP) over the last 12 years, with Sep 2025 value amounting to -$20.3 million.
- Ani Pharmaceuticals' Other Gross PP&E Adjustments rose 1.45% to -$20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.8 million, marking a year-over-year decrease of 253.22%. This contributed to the annual value of $100.6 million for FY2024, which is 29.74% up from last year.
- Ani Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$20.3 million in Q3 2025, which was up 49.99% from -$40.7 million recorded in Q2 2025.
- In the past 5 years, Ani Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $100.6 million during Q4 2024, and its lowest value of -$60.3 million during Q1 2025.
- Its 3-year average for Other Gross PP&E Adjustments is -$3.1 million, with a median of -$20.6 million in 2024.
- As far as peak fluctuations go, Ani Pharmaceuticals' Other Gross PP&E Adjustments spiked by 34.39% in 2022, and later slumped by 217.99% in 2024.
- Over the past 5 years, Ani Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $75.6 million in 2021, then grew by 0.44% to $76.0 million in 2022, then climbed by 2.07% to $77.5 million in 2023, then grew by 29.74% to $100.6 million in 2024, then climbed by 1.45% to -$20.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$20.3 million for Q3 2025, versus -$40.7 million for Q2 2025 and -$60.3 million for Q1 2025.